Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Learn which credit card offers the best cash back bonus. Compare different cards and make an informed decision today.
26,675 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Inflation stretches budgets and Social Security benefits, even with a potential bigger 2027 social security. This gui...
NVIDIA is at the center of AI-driven growth, and the latest update from CEO Jensen Huang has investors buzzing. This ...
Micron stock has swung on memory cycles, auto-chip demand, and big backlog talk. This article examines whether a deal...
As AI data centers ramp up, two independent power producers headline the market: Constellation Energy and Vistra. Thi...
A landmark ruling reshapes how investors view the Fed's independence and policy credibility. This could translate int...
Stellantis stands at a defining juncture. A strategic call on brand focus and EV spending could reshape profitability...
Lucid has set a production target, but many investors wonder if the pace will match the plan. This deep dive explains...
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
Cerebras hit the market with fireworks, then cooled off quickly. This guide explains what happened, how to value the ...
The Macy's 2026 earnings call will reveal how a storied department store navigates digital growth, store productivity...
The AI boom isn’t over yet, according to seasoned investor Paul Tudor Jones Says. This piece breaks down why the rall...